Experience
Avara

Experience Avara

Andrea Baiocchi


Recent Posts

May 24, 2018 2:37:00 PM

Providing Flexible Capabilities to Meet Market Demand for Sterile Fill-Finish Services

by Andrea Baiocchi


AS PUBLISHED IN Q2 2018 PHARMA'S ALMANAC

Demand for aseptic fill-finish contract manufacturing services is increasing as APIs become more complex and more biologic drugs reach the market. Biopharmaceutical companies are relying on contract development and manufacturing organizations (CDMOs) with the highly specialized equipment and capabilities required to ensure the production of high-quality, safe sterile drug products. Avara Pharmaceutical Services, with the acquisition of Pfizer’s Liscate, Italy facility, has added flexible, sterile fill-finish capabilities to its extensive portfolio of API and drug product development and manufacturing services.

Read More [fa icon="long-arrow-right"]